Skip to main content
Clinical Trials/DRKS00021724
DRKS00021724
Not yet recruiting
Not Applicable

Pilot study to distinguish between intracerebral hemorrhage and ischemic stroke using a non-invasive acustoscerebrography in combination with established serum biomarkers.

ZNN, Klinik für Neurologie Universitätsklinikum Frankfurt a.M.0 sites40 target enrollmentMay 13, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
I63
Sponsor
ZNN, Klinik für Neurologie Universitätsklinikum Frankfurt a.M.
Enrollment
40
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 13, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
ZNN, Klinik für Neurologie Universitätsklinikum Frankfurt a.M.

Eligibility Criteria

Inclusion Criteria

  • (1\) age \= 18 years
  • (2\) Relevant neurological deficit, National Institute of Health Stroke Scale (NIHSS) \=6
  • (3\) Admission to hospital within 6 hours of symptom onset.
  • (4\) Evidence of an occlusion of the M1\- or M2\-artery on computed tomography (CT)\-angiography or evidence of intracerebral hemorrhage in a supratentorial location

Exclusion Criteria

  • (1\) Prior history of stroke (TIA, ischemia, hemorrhage) within the last months.
  • (2\) Known history of brain Tumor
  • (3\) Traumatic brain injury within the last 3 months (including head impact at symptom onset)

Outcomes

Primary Outcomes

Not specified

Similar Trials